Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Diabetes Technology and Emerging Therapies
This week's episode explores cutting-edge diabetes technologies, emerging therapies, and related metabolic research, featuring discussions on artificial pancreas systems, diabetes prevention, and novel treatment approaches.
Bibliography
1. The Artificial Pancreas and Type 1 Diabetes.
Authors: Nwokolo M, Hovorka R
Journal: The Journal of clinical endocrinology and metabolism, 2023 Jun 16
PMID: 36734145
DOI: 10.1210/clinem/dgad068
2. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Authors: Herold KC, Bundy BN, Long SA, et al.
Journal: The New England journal of medicine, 2019 Aug 15
PMID: 31180194
DOI: 10.1056/NEJMoa1902226
3. International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring.
Authors: Pemberton JS, Andrews RC, Barnard-Kelly K, et al.
Journal: Diabetes, obesity & metabolism, 2026 Apr
PMID: 41582769
DOI: 10.1111/dom.70460
4. Real-World Efficacy of Inclisiran in Veneto Region (Italy): The INCLIVEN Multicenter Registry.
Authors: Briani F, Sani E, Venturi G, et al.
Journal: Cardiovascular drugs and therapy, 2026 Apr
PMID: 40663298
DOI: 10.1007/s10557-025-07749-3
5. The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerations.
Authors: Meçani R, Muka T, Cigler M, et al.
Journal: Diabetic medicine : a journal of the British Diabetic Association, 2026 Apr
PMID: 41578663
DOI: 10.1111/dme.70220
6. Skeletal muscle morphology and metabolism in patients with heart failure compared to healthy controls: a systematic review and meta-analysis.
Authors: Prokopidis K, McCluskey M, Schmid V, et al.
Journal: Journal of applied physiology (Bethesda, Md. : 1985), 2026 Apr 1
PMID: 41665168
DOI: 10.1152/japplphysiol.00959.2025
7. Clinical Characterization of Atypical Diabetes: Insights from the GENEPEDIAB Study into the Spectrum Between Type 1 and Monogenic Diabetes.
Authors: Harvengt A, Pirlot G, Denizli L, et al.
Journal: Cells, 2026 Mar 7
PMID: 41827917
DOI: 10.3390/cells15050484
8. Dysglycemia and Cardiometabolic Risk: Pathophysiological Rationale and the Emerging Role of Nutraceuticals in Integrated Prevention.
Authors: Cicero AFG, Scapagnini G, Grassi D, et al.
Journal: Nutrients, 2026 Mar 8
PMID: 41830038
DOI: 10.3390/nu18050868
9. Joint TOS/OMA/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach.
Authors: Alexander L, Purnell JQ, Burridge K, et al.
Journal: Obesity (Silver Spring, Md.), 2026 Apr
PMID: 41782434
DOI: 10.1002/oby.70164
10. A randomized, double-blind, crossover study of acute low-level night-time road traffic noise: effects on vascular function, sleep, and proteomic signatures in healthy adults.
Authors: Hahad O, Foos P, Hübner J, et al.
Journal: Cardiovascular research, 2026 Mar 26
PMID: 41740584
DOI: 10.1093/cvr/cvag028
Authors: Nwokolo M, Hovorka R
Journal: The Journal of clinical endocrinology and metabolism, 2023 Jun 16
PMID: 36734145
DOI: 10.1210/clinem/dgad068
2. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Authors: Herold KC, Bundy BN, Long SA, et al.
Journal: The New England journal of medicine, 2019 Aug 15
PMID: 31180194
DOI: 10.1056/NEJMoa1902226
3. International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring.
Authors: Pemberton JS, Andrews RC, Barnard-Kelly K, et al.
Journal: Diabetes, obesity & metabolism, 2026 Apr
PMID: 41582769
DOI: 10.1111/dom.70460
4. Real-World Efficacy of Inclisiran in Veneto Region (Italy): The INCLIVEN Multicenter Registry.
Authors: Briani F, Sani E, Venturi G, et al.
Journal: Cardiovascular drugs and therapy, 2026 Apr
PMID: 40663298
DOI: 10.1007/s10557-025-07749-3
5. The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerations.
Authors: Meçani R, Muka T, Cigler M, et al.
Journal: Diabetic medicine : a journal of the British Diabetic Association, 2026 Apr
PMID: 41578663
DOI: 10.1111/dme.70220
6. Skeletal muscle morphology and metabolism in patients with heart failure compared to healthy controls: a systematic review and meta-analysis.
Authors: Prokopidis K, McCluskey M, Schmid V, et al.
Journal: Journal of applied physiology (Bethesda, Md. : 1985), 2026 Apr 1
PMID: 41665168
DOI: 10.1152/japplphysiol.00959.2025
7. Clinical Characterization of Atypical Diabetes: Insights from the GENEPEDIAB Study into the Spectrum Between Type 1 and Monogenic Diabetes.
Authors: Harvengt A, Pirlot G, Denizli L, et al.
Journal: Cells, 2026 Mar 7
PMID: 41827917
DOI: 10.3390/cells15050484
8. Dysglycemia and Cardiometabolic Risk: Pathophysiological Rationale and the Emerging Role of Nutraceuticals in Integrated Prevention.
Authors: Cicero AFG, Scapagnini G, Grassi D, et al.
Journal: Nutrients, 2026 Mar 8
PMID: 41830038
DOI: 10.3390/nu18050868
9. Joint TOS/OMA/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach.
Authors: Alexander L, Purnell JQ, Burridge K, et al.
Journal: Obesity (Silver Spring, Md.), 2026 Apr
PMID: 41782434
DOI: 10.1002/oby.70164
10. A randomized, double-blind, crossover study of acute low-level night-time road traffic noise: effects on vascular function, sleep, and proteomic signatures in healthy adults.
Authors: Hahad O, Foos P, Hübner J, et al.
Journal: Cardiovascular research, 2026 Mar 26
PMID: 41740584
DOI: 10.1093/cvr/cvag028
